Our Portfolio
BioRewards Plasma Services is Alpha-1 Plasma Holdings’ flagship operating company and an emerging leader in the independent plasma collection industry. Focused on delivering high-quality source and hyperimmune plasma to pharmaceutical manufacturers worldwide, BioRewards is backed by a leadership team with over 100 years of combined industry experience.
Through strategic oversight, equity sponsorship from Alpha-1, and committed debt financing, BioRewards is positioned to deploy over $100 million to develop more than 20 state-of-the-art plasma collection centers across the U.S. over the next three years. Leveraging advanced technology, the platform is designed to optimize donor experience, operational efficiency, and plasma supply reliability at scale.
The BioRewards Advantage
Strategic Growth Plan
BioRewards is executing a scalable, capital-backed expansion plan to develop 20+ plasma collection centers across the U.S. by 2028. Each facility is designed to collect 50,000+ liters annually at maturity, contributing meaningfully to the global plasma supply chain.
Regulatory Excellence
All centers are being developed to meet or exceed FDA and, where applicable, EMA licensure standards. Our leadership team ensures rigorous quality control and compliance, delivering a safe, consistent, and high-integrity plasma supply.
Donor-Centric Approach
We prioritize a high-quality donor experience, recognizing that the individuals who donate plasma are the foundation of this life-saving industry. From site design to digital engagement, every touchpoint is built with the donor in mind.
Proven Leadership
Led by CEO Charles Auger and COO Chris Barber, BioRewards is backed by a leadership team with over 100 years of collective experience from leading global plasma organizations. This operational expertise drives execution and scale.
Technology-Enabled Operations
BioRewards leverages advanced data analytics, AI tools, and digital workflows to drive performance across site selection, donor engagement, and center-level operations. This includes optimizing donor scheduling, reducing wait times, improving throughput, and enhancing site-level efficiency.
Let’s Start a Conversation
Whether you’re an investor, industry partner, or experienced operator, we welcome the opportunity to connect. Reach out to learn how Alpha-1 Plasma Holdings is building the future of plasma infrastructure — and how you can be a part of it.